All Comments by Nikolaos K. Robakis

  1. Accumulation of SNAP-25 immunoreactive material in axons of Alzheimer's disease.
  2. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease.
  3. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs.
  4. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.
  5. Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene.
  6. Expression profiles of multiple genes in single neurons of Alzheimer's disease.
  7. Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid.
  8. Senile dementia with tangles (tangle predominant form of senile dementia).
  9. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.
  10. Genetic studies on chromosome 12 in late-onset Alzheimer disease.
  11. Treatment of Alzheimer's disease.
  12. Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein.
  13. Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease.
  14. A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein.
  15. Immunologic treatment of Alzheimer's disease.